866-997-4948(US-Canada Toll Free)

India Escitalopram Market Research Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 111 Pages

The global Escitalopram market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

India plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Escitalopram development status and future trend in India, focuses on top players in India, also splits Escitalopram by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in India market include
Forest Laboratories(US)
H.Lundbeck A/S(DK)
Amneal Pharmaceuticals(US)
Aurobindo Pharma(IN)
Hetero Drugs(IN)
Macleods Pharmaceuticals(IN)
Silarx Pharmacueticals(US)
Apotex(CA)
Hikma Pharmaceuticals(UK)
Jubilant Pharma(SG)
Lupin Limited(IN)
Prinston Pharmaceutical(US)
STI Pharma(US)
TEVA Pharmaceutical(US)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Solution
Tablet
Others

On the basis of the end users/Application, this report covers
Hospitals and Clinics
Individual Use
Others

Table of Contents

India Escitalopram Market Research Report 2018
1 Escitalopram Overview
1.1 Product Overview and Scope of Escitalopram
1.2 Classification of Escitalopram by Product Category
1.2.1 India Escitalopram Sales (K Units) Comparison by Type (2013-2025)
1.2.2 India Escitalopram Sales (K Units) Market Share by Type in 2017
1.2.3 Solution
1.2.4 Tablet
1.2.5 Others
1.3 India Escitalopram Market by Application/End Users
1.3.1 India Escitalopram Sales (K Units) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals and Clinics
1.3.3 Individual Use
1.3.4 Others
1.4 India Revenue and Sales of Escitalopram (2013-2025)
1.4.1 India Escitalopram Sales (K Units) and Growth Rate (%)(2013-2025)
1.4.2 India Escitalopram Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 India Escitalopram Market Competition by Players/Manufacturers
2.1 India Escitalopram Sales (K Units) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 India Escitalopram Revenue and Share by Players/Manufacturers (2013-2018)
2.3 India Escitalopram Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 India Escitalopram Market Competitive Situation and Trends
2.4.1 India Escitalopram Market Concentration Rate
2.4.2 India Escitalopram Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in India Market
2.5 India Players/Manufacturers Escitalopram Manufacturing Base Distribution, Sales Area, Product Type

3 India Escitalopram Sales and Revenue (Value) by Type (2013-2018)
3.1 India Escitalopram Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
3.2 India Escitalopram Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 India Escitalopram Price (USD/Unit) by Type (2013-2018)
3.4 India Escitalopram Sales Growth Rate (%) by Type (2013-2018)

4 India Escitalopram Sales by Application (2013-2018)
4.1 India Escitalopram Sales (K Units) and Market Share by Application (2013-2018)
4.2 India Escitalopram Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 India Escitalopram Players/Suppliers Profiles and Sales Data
5.1 Forest Laboratories(US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Escitalopram Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Forest Laboratories(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 H.Lundbeck A/S(DK)
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Escitalopram Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 H.Lundbeck A/S(DK) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Amneal Pharmaceuticals(US)
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Escitalopram Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Amneal Pharmaceuticals(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Aurobindo Pharma(IN)
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Escitalopram Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Aurobindo Pharma(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Hetero Drugs(IN)
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Escitalopram Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Hetero Drugs(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Macleods Pharmaceuticals(IN)
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Escitalopram Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Macleods Pharmaceuticals(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 Silarx Pharmacueticals(US)
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Escitalopram Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 Silarx Pharmacueticals(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 Apotex(CA)
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Escitalopram Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 Apotex(CA) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview
5.9 Hikma Pharmaceuticals(UK)
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Escitalopram Product Category, Application and Specification
5.9.2.1 Product A
5.9.2.2 Product B
5.9.3 Hikma Pharmaceuticals(UK) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.9.4 Main Business/Business Overview
5.10 Jubilant Pharma(SG)
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Escitalopram Product Category, Application and Specification
5.10.2.1 Product A
5.10.2.2 Product B
5.10.3 Jubilant Pharma(SG) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.10.4 Main Business/Business Overview
5.11 Lupin Limited(IN)
5.12 Prinston Pharmaceutical(US)
5.13 STI Pharma(US)
5.14 TEVA Pharmaceutical(US)

6 Escitalopram Manufacturing Cost Analysis
6.1 Escitalopram Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Escitalopram

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Escitalopram Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Escitalopram Major Manufacturers in 2017
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 India Escitalopram Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 India Escitalopram Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
10.2 India Escitalopram Sales (K Units) Forecast by Type (2018-2025)
10.3 India Escitalopram Sales (K Units) Forecast by Application (2018-2025)

11 Research Findings and Conclusion

List of Table

List of Tables and Figures

Figure India Market Size (Million USD) Status and Outlook (2013-2025)
Table Escitalopram Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Escitalopram Sales (K Units) by Application (2017-2025)
Figure Product Picture of Escitalopram
Table India Escitalopram Sales (K Units) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure India Escitalopram Sales Volume Market Share by Type in 2017
Figure Solution Product Picture
Figure Tablet Product Picture
Figure Others Product Picture
Figure India Escitalopram Sales (K Units) Comparison by Application (2013-2025)
Figure India Sales Market Share (%) of Escitalopram by Application in 2017
Figure Hospitals and Clinics Examples
Figure Individual Use Examples
Figure Others Examples
Figure India Escitalopram Sales (K Units) and Growth Rate (%)(2013-2025)
Figure India Escitalopram Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table India Escitalopram Sales of Key Players/Manufacturers (2013-2018)
Table India Escitalopram Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 India Escitalopram Sales Share (%) by Players/Manufacturers
Figure 2017 India Escitalopram Sales Share (%) by Players/Manufacturers
Table India Escitalopram Revenue by Players/Manufacturers (2013-2018)
Table India Escitalopram Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 India Escitalopram Revenue Share (%) by Players/Manufacturers
Figure 2017 India Escitalopram Revenue Share (%) by Players/Manufacturers
Table India Market Escitalopram Average Price (USD/Unit) of Key Players/Manufacturers (2013-2018)
Figure India Market Escitalopram Average Price (USD/Unit) of Key Players/Manufacturers in 2017
Figure India Escitalopram Market Share of Top 3 Players/Manufacturers
Figure India Escitalopram Market Share of Top 5 Players/Manufacturers
Table India Players/Manufacturers Escitalopram Manufacturing Base Distribution and Sales Area
Table India Players/Manufacturers Escitalopram Product Category
Table India Escitalopram Sales (K Units) by Type (2013-2018)
Table India Escitalopram Sales Share (%) by Type (2013-2018)
Figure India Escitalopram Sales Share (%) by Type (2013-2018)
Figure India Escitalopram Sales Market Share (%) by Type in 2017
Table India Escitalopram Revenue (Million USD) and Market Share by Type (2013-2018)
Table India Escitalopram Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Escitalopram by Type (2013-2018)
Figure Revenue Market Share of Escitalopram by Type in 2017
Table India Escitalopram Price (USD/Unit) by Type (2013-2018)
Figure India Escitalopram Sales Growth Rate (%) by Type (2013-2018)
Table India Escitalopram Sales (K Units) by Application (2013-2018)
Table India Escitalopram Sales Market Share (%) by Application (2013-2018)
Figure India Escitalopram Sales Market Share (%) by Application (2013-2018)
Figure India Escitalopram Sales Market Share (%) by Application in 2017
Table India Escitalopram Sales Growth Rate (%) by Application (2013-2018)
Figure India Escitalopram Sales Growth Rate (%) by Application (2013-2018)
Table Forest Laboratories(US) Escitalopram Basic Information List
Table Forest Laboratories(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Forest Laboratories(US) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Forest Laboratories(US) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Forest Laboratories(US) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table H.Lundbeck A/S(DK) Escitalopram Basic Information List
Table H.Lundbeck A/S(DK) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure H.Lundbeck A/S(DK) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure H.Lundbeck A/S(DK) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure H.Lundbeck A/S(DK) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Amneal Pharmaceuticals(US) Escitalopram Basic Information List
Table Amneal Pharmaceuticals(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Amneal Pharmaceuticals(US) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Amneal Pharmaceuticals(US) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Amneal Pharmaceuticals(US) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Aurobindo Pharma(IN) Escitalopram Basic Information List
Table Aurobindo Pharma(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Aurobindo Pharma(IN) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Aurobindo Pharma(IN) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Aurobindo Pharma(IN) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Hetero Drugs(IN) Escitalopram Basic Information List
Table Hetero Drugs(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Hetero Drugs(IN) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Hetero Drugs(IN) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Hetero Drugs(IN) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Macleods Pharmaceuticals(IN) Escitalopram Basic Information List
Table Macleods Pharmaceuticals(IN) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Macleods Pharmaceuticals(IN) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Macleods Pharmaceuticals(IN) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Macleods Pharmaceuticals(IN) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Silarx Pharmacueticals(US) Escitalopram Basic Information List
Table Silarx Pharmacueticals(US) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Silarx Pharmacueticals(US) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Silarx Pharmacueticals(US) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Silarx Pharmacueticals(US) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Apotex(CA) Escitalopram Basic Information List
Table Apotex(CA) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Apotex(CA) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Apotex(CA) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Apotex(CA) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Hikma Pharmaceuticals(UK) Escitalopram Basic Information List
Table Hikma Pharmaceuticals(UK) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Hikma Pharmaceuticals(UK) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Hikma Pharmaceuticals(UK) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Hikma Pharmaceuticals(UK) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Jubilant Pharma(SG) Escitalopram Basic Information List
Table Jubilant Pharma(SG) Escitalopram Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Jubilant Pharma(SG) Escitalopram Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Jubilant Pharma(SG) Escitalopram Sales Market Share (%) in India (2013-2018)
Figure Jubilant Pharma(SG) Escitalopram Revenue Market Share (%) in India (2013-2018)
Table Lupin Limited(IN) Escitalopram Basic Information List
Table Prinston Pharmaceutical(US) Escitalopram Basic Information List
Table STI Pharma(US) Escitalopram Basic Information List
Table TEVA Pharmaceutical(US) Escitalopram Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Escitalopram
Figure Manufacturing Process Analysis of Escitalopram
Figure Escitalopram Industrial Chain Analysis
Table Raw Materials Sources of Escitalopram Major Players/Manufacturers in 2017
Table Major Buyers of Escitalopram
Table Distributors/Traders List
Figure India Escitalopram Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure India Escitalopram Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Escitalopram Price (USD/Unit) Trend Forecast (2018-2025)
Table India Escitalopram Sales (K Units) Forecast by Type (2018-2025)
Figure India Escitalopram Sales (K Units) Forecast by Type (2018-2025)
Figure India Escitalopram Sales Volume Market Share Forecast by Type in 2025
Table India Escitalopram Sales (K Units) Forecast by Application (2018-2025)
Figure India Escitalopram Sales Volume Market Share Forecast by Application (2018-2025)
Figure India Escitalopram Sales Volume Market Share Forecast by Application in 2025

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *